are glp 1 safe for kidneys Potential kidney-protective and other effects of GLP-1 receptor SGLT2 vs GLP-1 for CKD:

Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases

For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate

No, Medicare generally does not cover GLP-1 medications for weight loss

To understand how Artemis can help you tackle your GLP-1 strategy, reach out to [email protected]

Liraglutide treatment had a better influence on BMI and waist circumference reduction than combined therapy, but the latter significantly decreased total testosterone and caused less nausea [94]